Development Programs
Bile Acid Receptor Activators
Lead candidate JO-001, a modified bile acid, is designed to activate bile acid receptor signaling. This preclinical drug candidate is being developed to treat or prevent fatty liver disease, obesity, and type 2 diabetes.
01
Liver–Brain Neuroimmune Axis Modulators
Therapeutics targeting hepatic neuroimmune signaling and the vagal liver–brain circuit for neurodegenerative disease.
02
Digital Research Tools
Mobile applications that put everyday molecular biology workflows in a researcher’s pocket, including Gene Search for NCBI gene and protein lookup and Plasmid Editor for cloning design.